Taysha Gene Therapies (TSHA) Earnings Date, Estimates & Call Transcripts $1.60 +0.01 (+0.63%) Closing price 04:00 PM EasternExtended Trading$1.62 +0.02 (+1.31%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Taysha Gene Therapies Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 13After Market ClosesEstimatedActual EPS (Feb. 26) -$0.07 Beat By $0.01 Consensus EPS (Feb. 26) -$0.08 Taysha Gene Therapies announced Q4 2024 earnings on February 26, 2025, reporting an EPS of -$0.07, which beat analysts' consensus estimates of -$0.08 by $0.01. Quarterly revenue was reported to be $2.02 million, below analyst estimates of $2.05 million. With a trailing EPS of $0.63 and a P/E Ratio of 2.54, Taysha Gene Therapies' earnings are expected to decrease next year, from ($0.35) to ($0.37) per share. Conference CallConference Call TranscriptTSHA Upcoming EarningsTaysha Gene Therapies' next earnings date is estimated for Tuesday, May 13, 2025, based off prior year's reporting schedules. Get Taysha Gene Therapies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Taysha Gene Therapies and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTSHA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TSHA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Taysha Gene Therapies Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.35) EPSNext Year EPS Consensus Estimate: ($0.37) EPS Taysha Gene Therapies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)-------2/26/2025Q4 2024-$0.08-$0.07+$0.01-$0.07$2.05M$2.02M8/12/2024Q2 2024-$0.10-$0.09+$0.01-$0.09$3.62M$1.11M5/14/2024Q1 2024-$0.11-$0.10+$0.01-$0.10$3.70M$3.41M3/19/2024Q4 2023-$0.35+$0.35-$0.22$4.75M$3.60M11/14/2023Q3 2023-$0.13-$0.13-$0.67$2.65M$4.75M8/14/2023Q2 2023-$0.31-$0.38 -$0.07-$0.38$2.00M$2.40M5/11/2023Q1 2023-$0.39-$0.28+$0.11-$0.28-$4.71M3/28/2023Q4 2022-$0.41-$0.99 -$0.58-$0.99-$2.50M Taysha Gene Therapies Earnings - Frequently Asked Questions When is Taysha Gene Therapies's earnings date? Taysha Gene Therapies has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on TSHA's earnings history. Did Taysha Gene Therapies beat their earnings estimates last quarter? In the previous quarter, Taysha Gene Therapies (NASDAQ:TSHA) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.08) by $0.01. Learn more on analysts' earnings estimate vs. TSHA's actual earnings. How can I listen to Taysha Gene Therapies's earnings conference call? The conference call for Taysha Gene Therapies's latest earnings report can be listened to online. Listen to Conference Call How can I read Taysha Gene Therapies's conference call transcript? The conference call transcript for Taysha Gene Therapies's latest earnings report can be read online. Read Transcript How much revenue does Taysha Gene Therapies generate each year? Taysha Gene Therapies (NASDAQ:TSHA) has a recorded annual revenue of $9.92 million. How much profit does Taysha Gene Therapies generate each year? Taysha Gene Therapies (NASDAQ:TSHA) has a recorded net income of -$111.57 million. TSHA has generated $0.63 earnings per share over the last four quarters. What is Taysha Gene Therapies's price-to-earnings ratio? Taysha Gene Therapies (NASDAQ:TSHA) has a trailing price-to-earnings ratio of 2.54. What is Taysha Gene Therapies's EPS forecast for next year? Taysha Gene Therapies's earnings are expected to decrease from ($0.35) per share to ($0.37) per share in the next year. More Earnings Resources from MarketBeat Related Companies SNDX Earnings Results VIR Earnings Results NRIX Earnings Results PRAX Earnings Results ADPT Earnings Results DAWN Earnings Results ARDX Earnings Results GPCR Earnings Results CALT Earnings Results NTLA Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance? This page (NASDAQ:TSHA) was last updated on 2/28/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored401K Savers Taking Advantage of “Tariffs” With Odd, 2-Word MoveYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taysha Gene Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taysha Gene Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSHA Stock Alerts